NCT01656135View on ClinicalTrials.gov

Reference Group Trial for The ONE Study

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
End-stage Renal FailureKidney Graft Rejection
Interventions
OTHER

Blood drawing for immune monitoring and questionnaires

Trial Locations (8)

13353

Charite Campus Virchow-Klinikum, Berlin

20132

Ospedale San Raffaele, Milan

44093

CHU de Nantes Hotel-Dieu, Nantes

93053

University Hospital Regensburg, Regensburg

94143

University of California San Francisco, San Francisco

02114

Massachusetts General Hospital, Boston

SE1 9RT

Guy's Hospital in affiliation with King's College London, London

OX3 7LE

Churchill Hospital in affiliation with the University of Oxford, Oxford

All Listed Sponsors
collaborator

European Commission

OTHER

lead

University of Regensburg

OTHER

NCT01656135 - Reference Group Trial for The ONE Study | Biotech Hunter | Biotech Hunter